Overview

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder

Status:
Terminated

Trial end date:
2019-12-06

Target enrollment:

Participant gender:

Summary

The purpose of Project 2 is to execute phase I functional magnetic resonance imaging (fMRI) studies to assess the effects of lorcaserin on brain target engagement (measured by fMRI brain activation and neural connectivity) in cocaine use disorder (CocUD) subjects and/or opioid use disorder.

Phase:

Phase 1

Details

Lead Sponsor:

Virginia Commonwealth University

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Analgesics, Opioid
Cocaine